Onconetix, Inc. Noncash or Part Noncash Acquisition, Inventory Acquired
Onconetix, Inc. (ONCO) reported Noncash or Part Noncash Acquisition, Inventory Acquired of $400.00 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionInventoryAcquired1 · last filed 2025-06-02
- Onconetix, Inc. noncash or part noncash acquisition, inventory acquired for the quarter ending 2024-06-30 was $400.00K.
- Onconetix, Inc. noncash or part noncash acquisition, inventory acquired for the quarter ending 2023-12-31 was $1.20M.
- Onconetix, Inc. noncash or part noncash acquisition, inventory acquired for the quarter ending 2023-09-30 was $0.00.
- Onconetix, Inc. noncash or part noncash acquisition, inventory acquired for fiscal 2023 was $12.95M.
| Period end | Noncash or Part Noncash Acquisition, Inventory Acquired 3 month | Noncash or Part Noncash Acquisition, Inventory Acquired 6 month | Noncash or Part Noncash Acquisition, Inventory Acquired 9 month | Noncash or Part Noncash Acquisition, Inventory Acquired 12 month |
|---|---|---|---|---|
| 2024-06-30 | $400.00K 10-Q · filed 2024-08-29 | |||
| 2023-12-31 | $1.20M 10-Q · filed 2024-08-29 | $1.20M derived: sum of 2 quarters · filed 2024-12-10 | $12.95M 10-K · filed 2025-06-02 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-10 | $12.95M 10-Q · filed 2024-12-10 | ||
| 2023-06-30 | $12.95M 10-Q · filed 2024-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |